JG
MDGL icon

Jain Global’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jain Global’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
+10,965
New +$5.62M 0.02% 523
2026
Q1 		– Sell
-52,721
Closed -$30.7M – 1490
2025
Q4 		$30.7M Buy
+52,721
New +$26.9M 0.15% 140

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jain Global's MDGL Position: Q2 2026 in Review

Jain Global opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 10,965 shares worth $5.89M. The stake represents 0.02% of the portfolio and ranks #523 among its holdings. This is a return to the name: Jain Global previously reported a position in MDGL as recently as Q4 2025.

Jain Global first reported a position in MDGL in Q4 2025 and has held it in 2 quarters since. The position peaked at $30.7M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Jain Global held 10,965 shares of Madrigal Pharmaceuticals worth $5.89M as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.02% of Jain Global's portfolio in Q2 2026, its #523 holding.
  • Jain Global first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's Madrigal Pharmaceuticals position peaked at $30.7M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.